Mortality and Other Important Diabetes-Related Outcomes With Insulin vs Other Antihyperglycemic Therapies in Type 2 Diabetes

por Currie, Craig J., Poole, Chris D., Evans, Marc, Peters, John R., Morgan, Christopher Ll.
Publicado 2013

Improved glycaemic control by switching from insulin NPH to insulin glargine: a retrospective observational study

por Sharplin, Peter, Gordon, Jason, Peters, John R, Tetlow, Anthony P, Longman, Andrea J, McEwan, Philip
Publicado 2009

Switching from premixed insulin to glargine-based insulin regimen improves glycaemic control in patients with type 1 or type 2 diabetes: a retrospective primary care-based analysis

por Sharplin, Peter, Gordon, Jason, Peters, John R, Tetlow, Anthony P, Longman, Andrea J, McEwan, Philip
Publicado 2009

Impact of differing glucose‐lowering regimens on the pattern of association between glucose control and survival

por Currie, Craig J., Holden, Sarah E., Jenkins‐Jones, Sara, Morgan, Christopher Ll, Voss, Bernd, Rajpathak, Swapnil N., Alemayehu, Berhanu, Peters, John R., Engel, Samuel S.
Publicado 2017